Axoltis Pharma

Axoltis Pharma

Recherche en biotechnologie

Lyon, Auvergne-Rhône-Alpes 2 352 abonnés

The CNS Regeneration Company

À propos

Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.

Secteur
Recherche en biotechnologie
Taille de l’entreprise
11-50 employés
Siège social
Lyon, Auvergne-Rhône-Alpes
Type
Société civile/Société commerciale/Autres types de sociétés
Domaines
neurodegenerative diseases, neurodegeneration, spinal cord injury, peptide, neuroprotection, neural repair, regeneration, drug, biotechnology, pharma, CNS, neurology, ALS, Parkinson et Multiple Sclerosis

Lieux

Employés chez Axoltis Pharma

Nouvelles

Pages similaires